Cargando…

Autoantibody profiles are associated with specific clinical features in psychotic disorders

INTRODUCTION: Immune system abnormalities exist across a range of psychiatric disorders. Autoimmunity, characterized by the production of antibodies against the body’s own antigens, is a feature of immune system dysfunction and could play a role in mental disorder pathophysiology. Better understandi...

Descripción completa

Detalles Bibliográficos
Autores principales: Schubert, K.O., Falk, A. Jernbom, Galletly, C., Just, D., Toben, C., Baune, B., Clark, S., Liu, D., Nilsson, P., Manberg, A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9480266/
http://dx.doi.org/10.1192/j.eurpsy.2021.2026
_version_ 1784791013993218048
author Schubert, K.O.
Falk, A. Jernbom
Galletly, C.
Just, D.
Toben, C.
Baune, B.
Clark, S.
Liu, D.
Nilsson, P.
Manberg, A.
author_facet Schubert, K.O.
Falk, A. Jernbom
Galletly, C.
Just, D.
Toben, C.
Baune, B.
Clark, S.
Liu, D.
Nilsson, P.
Manberg, A.
author_sort Schubert, K.O.
collection PubMed
description INTRODUCTION: Immune system abnormalities exist across a range of psychiatric disorders. Autoimmunity, characterized by the production of antibodies against the body’s own antigens, is a feature of immune system dysfunction and could play a role in mental disorder pathophysiology. Better understanding of the associations of auto-immunoglobulin G (IgG) repertoires with clinical features of mental illness could yield novel models of psychosis pathophysiology and markers for biological patient stratification. OBJECTIVES: To undertake global screening for auto-IgG expression in a large cohort of people with psychotic disorders; to determine whether associations exist between autoantibody expression and clinical features. METHODS: Cross-sectional quantification of auto-IgGs in blood plasma of 461 people with established psychotic disorder diagnoses. For global screening, pooled samples of phenotypically representative patient groups were exposed to planar protein microarrays containing 42,000 human antigens. For targeted profiling, expression levels of 380 autoantibodies were quantified by suspension bead array (SBA) in each patient’s plasma. RESULTS: We identified highly individual autoantibody profiles with no evidence for co-expression patterns. We found 6 autoantibodies robustly associated with specific psychopathology: anti-AP3B2, detected in 5% of the cohort of whom 100% had persecutory delusions; anti-TDO2 (5% of the cohort, 100% hallucinations); anti-CRYGN (4%, 86% initial insomnia); anti-APMAP (3%, 86% poor appetite); anti-OLFM1 (2.5%, 100% above median cognitive function); and anti-WHAMMP3 (2%, 90% anhedonia and dysphoria). Examination of the auto-IgG binding site on the TDO2 protein revealed a putative pathophysiological mechanism involving the kynurenine pathway. CONCLUSIONS: We identified 6 frequently occurring autoantibodies that were associated with specific clinical features in people with psychotic disorders. DISCLOSURE: No significant relationships.
format Online
Article
Text
id pubmed-9480266
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Cambridge University Press
record_format MEDLINE/PubMed
spelling pubmed-94802662022-09-29 Autoantibody profiles are associated with specific clinical features in psychotic disorders Schubert, K.O. Falk, A. Jernbom Galletly, C. Just, D. Toben, C. Baune, B. Clark, S. Liu, D. Nilsson, P. Manberg, A. Eur Psychiatry Abstract INTRODUCTION: Immune system abnormalities exist across a range of psychiatric disorders. Autoimmunity, characterized by the production of antibodies against the body’s own antigens, is a feature of immune system dysfunction and could play a role in mental disorder pathophysiology. Better understanding of the associations of auto-immunoglobulin G (IgG) repertoires with clinical features of mental illness could yield novel models of psychosis pathophysiology and markers for biological patient stratification. OBJECTIVES: To undertake global screening for auto-IgG expression in a large cohort of people with psychotic disorders; to determine whether associations exist between autoantibody expression and clinical features. METHODS: Cross-sectional quantification of auto-IgGs in blood plasma of 461 people with established psychotic disorder diagnoses. For global screening, pooled samples of phenotypically representative patient groups were exposed to planar protein microarrays containing 42,000 human antigens. For targeted profiling, expression levels of 380 autoantibodies were quantified by suspension bead array (SBA) in each patient’s plasma. RESULTS: We identified highly individual autoantibody profiles with no evidence for co-expression patterns. We found 6 autoantibodies robustly associated with specific psychopathology: anti-AP3B2, detected in 5% of the cohort of whom 100% had persecutory delusions; anti-TDO2 (5% of the cohort, 100% hallucinations); anti-CRYGN (4%, 86% initial insomnia); anti-APMAP (3%, 86% poor appetite); anti-OLFM1 (2.5%, 100% above median cognitive function); and anti-WHAMMP3 (2%, 90% anhedonia and dysphoria). Examination of the auto-IgG binding site on the TDO2 protein revealed a putative pathophysiological mechanism involving the kynurenine pathway. CONCLUSIONS: We identified 6 frequently occurring autoantibodies that were associated with specific clinical features in people with psychotic disorders. DISCLOSURE: No significant relationships. Cambridge University Press 2021-08-13 /pmc/articles/PMC9480266/ http://dx.doi.org/10.1192/j.eurpsy.2021.2026 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Abstract
Schubert, K.O.
Falk, A. Jernbom
Galletly, C.
Just, D.
Toben, C.
Baune, B.
Clark, S.
Liu, D.
Nilsson, P.
Manberg, A.
Autoantibody profiles are associated with specific clinical features in psychotic disorders
title Autoantibody profiles are associated with specific clinical features in psychotic disorders
title_full Autoantibody profiles are associated with specific clinical features in psychotic disorders
title_fullStr Autoantibody profiles are associated with specific clinical features in psychotic disorders
title_full_unstemmed Autoantibody profiles are associated with specific clinical features in psychotic disorders
title_short Autoantibody profiles are associated with specific clinical features in psychotic disorders
title_sort autoantibody profiles are associated with specific clinical features in psychotic disorders
topic Abstract
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9480266/
http://dx.doi.org/10.1192/j.eurpsy.2021.2026
work_keys_str_mv AT schubertko autoantibodyprofilesareassociatedwithspecificclinicalfeaturesinpsychoticdisorders
AT falkajernbom autoantibodyprofilesareassociatedwithspecificclinicalfeaturesinpsychoticdisorders
AT galletlyc autoantibodyprofilesareassociatedwithspecificclinicalfeaturesinpsychoticdisorders
AT justd autoantibodyprofilesareassociatedwithspecificclinicalfeaturesinpsychoticdisorders
AT tobenc autoantibodyprofilesareassociatedwithspecificclinicalfeaturesinpsychoticdisorders
AT bauneb autoantibodyprofilesareassociatedwithspecificclinicalfeaturesinpsychoticdisorders
AT clarks autoantibodyprofilesareassociatedwithspecificclinicalfeaturesinpsychoticdisorders
AT liud autoantibodyprofilesareassociatedwithspecificclinicalfeaturesinpsychoticdisorders
AT nilssonp autoantibodyprofilesareassociatedwithspecificclinicalfeaturesinpsychoticdisorders
AT manberga autoantibodyprofilesareassociatedwithspecificclinicalfeaturesinpsychoticdisorders